SecSonar.com

Simulations Plus, Inc. (SLP)

Simulations Plus, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Simulations Plus, Inc. (SLP) is a Medical - Healthcare Information Services company based in US with a market capitalization of $349.2M. Revenue grew 13.1% year-over-year and the company generated $17.4M in free cash flow. This page tracks SLP's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 243 employees · IPO Jun 18, 1997

Valuation

Valuation & price

$13.34 · as of May 17, 2026 · -36.0% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

2.80

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$20.84$16.13$11.42Jul 25Dec 25Jul 26Jul 7, 25$16.83Jul 9, 25$17.53Jul 11, 25$16.96Jul 15, 25$12.97Jul 17, 25$12.79Jul 21, 25$13.14Jul 23, 25$13.27Jul 25, 25$13.23Jul 29, 25$13.47Jul 31, 25$13.02Aug 4, 25$12.99Aug 6, 25$13.04Aug 11, 25$13.87Aug 13, 25$14.53Aug 15, 25$14.24Aug 19, 25$14.06Aug 21, 25$13.77Aug 25, 25$14.03Aug 27, 25$14.36Aug 29, 25$14.17Sep 3, 25$14.38Sep 5, 25$13.84Sep 9, 25$14.16Sep 11, 25$14.36Sep 16, 25$15.43Sep 18, 25$15.86Sep 22, 25$15.03Sep 24, 25$14.84Sep 26, 25$14.89Sep 30, 25$15.07Oct 2, 25$15.55Oct 6, 25$16.55Oct 8, 25$16.47Oct 10, 25$14.76Oct 14, 25$15.26Oct 16, 25$16.02Oct 21, 25$15.56Oct 23, 25$17.23Oct 27, 25$18.16Oct 29, 25$17.79Oct 31, 25$17.18Nov 4, 25$17.00Nov 6, 25$17.71Nov 10, 25$17.18Nov 12, 25$17.33Nov 14, 25$17.31Nov 18, 25$16.33Nov 20, 25$16.68Nov 25, 25$17.13Nov 28, 25$17.00Dec 2, 25$19.53Dec 4, 25$20.49Dec 8, 25$19.55Dec 10, 25$19.80Dec 12, 25$19.17Dec 16, 25$18.86Dec 18, 25$18.56Dec 22, 25$19.34Dec 24, 25$19.18Dec 29, 25$18.27Jan 2, 26$18.11Jan 6, 26$19.27Jan 8, 26$18.05Jan 12, 26$18.91Jan 14, 26$19.89Jan 16, 26$20.33Jan 21, 26$20.43Jan 23, 26$20.84Jan 27, 26$19.57Jan 29, 26$17.71Feb 2, 26$16.77Feb 4, 26$14.82Feb 9, 26$14.10Feb 11, 26$12.83Feb 13, 26$12.29Feb 18, 26$12.18Feb 20, 26$11.66Feb 24, 26$11.59Feb 26, 26$12.09Mar 2, 26$12.13Mar 4, 26$12.35Mar 6, 26$12.22Mar 10, 26$12.26Mar 12, 26$12.33Mar 17, 26$11.92Mar 19, 26$11.71Mar 23, 26$11.94Mar 25, 26$11.54Mar 27, 26$11.42Mar 31, 26$11.82Apr 2, 26$11.99Apr 7, 26$12.65Apr 9, 26$12.99Apr 13, 26$12.95Apr 15, 26$14.64Apr 17, 26$14.37Apr 22, 26$15.19Apr 24, 26$14.56Apr 28, 26$14.87Apr 30, 26$14.17May 4, 26$15.15May 6, 26$15.88May 8, 26$16.68May 12, 26$13.96May 14, 26$13.38May 18, 26$13.78May 20, 26$14.47May 22, 26$15.37May 28, 26$16.71Jun 1, 26$17.73Jun 3, 26$16.17Jun 5, 26$15.88Jun 9, 26$16.01Jun 11, 26$16.49Jun 15, 26$16.37Jun 17, 26$18.25Jun 22, 26$18.10Jun 24, 26$18.17Jun 26, 26$18.20Jul 2, 26$18.39
$11.3652-week range$20.84
Loading valuation history…

Fundamentals

Key fundamentals

$349.2M

Market cap

13.1%

Revenue growth (YoY)

58.4%

Gross margin

$17.4M

Free cash flow (USD)

-$31.7M

Net debt

Net cash position

0.6%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$20.0MFY 2017$24.1MFY 2018$29.7MFY 2019$34.0MFY 2020$41.6MFY 2021$46.5MFY 2022$53.9MFY 2023$59.6MFY 2024$70.0MFY 2025$79.2M
$20M$79.2M

Free cash flow by year

2016 → 2025

FY 2016$4.2MFY 2017$5.3MFY 2018$7.0MFY 2019$9.7MFY 2020$8.3MFY 2021$14.6MFY 2022$13.9MFY 2023$17.6MFY 2024$12.8MFY 2025$17.4M
$4.2M$17.4M

Gross margin by year

2021 → 2025

FY 202177.2%FY 202279.9%FY 202380.5%FY 202461.6%FY 202558.4%
77.2%58.4%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

8

Insider sells · 90 days

Earnings

Last report: 10-Q filed Apr 10, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider sellInsider Sell $134K · 10b5-1 PlanFiedler-Kelly Jill · President, Services Solutions · $133.8KJun 17, 2026Filing
  • 8-K eventMerger AgreementJun 17, 2026Filing
  • Insider sellInsider Sell $17K · 10b5-1 PlanFiedler-Kelly Jill · President, Services Solutions · $17.3KJun 16, 2026Filing
  • 8-K eventMerger Agreement ExecutedJun 16, 2026Filing
  • Insider sellInsider Sell $16K · 10b5-1 PlanDiBella John Anthony II · Chief Revenue Officer · $16.5KJun 4, 2026Filing
  • Insider sellInsider Sell $261K · 10b5-1 PlanWOLTOSZ WALTER S · Director, 10% Owner · $261.5KJun 2, 2026Filing
  • Insider sellInsider Sell $17K · 10b5-1 PlanFiedler-Kelly Jill · President, Services Solutions · $16.5KMay 13, 2026Filing
  • Insider sellInsider Sell $227K · 10b5-1 PlanWOLTOSZ WALTER S · Director, 10% Owner · $227KMay 5, 2026Filing
  • Insider sellInsider Sell $15K · 10b5-1 PlanDiBella John Anthony II · Chief Revenue Officer · $15KMay 5, 2026Filing
  • Insider sellInsider Sell $13K · 10b5-1 PlanDiBella John Anthony II · Chief Revenue Officer · $13.4KApr 16, 2026Filing

Questions

Frequently asked questions

What is Simulations Plus, Inc.'s market cap?

Simulations Plus, Inc. (SLP) has a market capitalization of $349.2M.

What is SLP's P/E ratio?

A meaningful P/E ratio is not available for SLP — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is SLP's price-to-book (P/B) ratio?

SLP trades at 2.80 times book value per share.

Are insiders buying SLP stock?

SEC Form 4 filings show no open-market insider buys at Simulations Plus, Inc. in the last 90 days (8 sells).

Same arena

Related companies in Medical - Healthcare Information Services

SOPH

SOPHiA GENETICS S.A.

$360M

TBRG

TruBridge, Inc.

$389.2M

CTEV

Claritev Corporation

$428.8M

SY

So-Young International Inc.

$263.7M

EVH

Evolent Health, Inc.

$443.7M

NRC

National Research Corporation

$449.9M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.